Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is becoming increasingly more common. Treatment for PDAC is dependent not only on stage at diagnosis, but complex anatomical relationships. Recently, the therapeutic approach to this disease has shifted from upfront surgery for technically resectable lesions t...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Seifeldin Awad, Ahmad M. Alkashash, Magi Amin, Samantha J. Baker, J. Bart Rose
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2020-05-01
Reeks:Frontiers in Oncology
Onderwerpen:
pancreatic duct adenocarcinoma (PDAC)
neoadjuvant chemotheraphy
CA 19-9–carbohydrate antigen 19-9
biomarker (development)
tumor biomarker
Online toegang:https://www.frontiersin.org/article/10.3389/fonc.2020.00620/full
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items